220 related articles for article (PubMed ID: 31803232)
1. Comprehensive Assessment of
Walker LC; Lattimore VL; Kvist A; Kleiblova P; Zemankova P; de Jong L; Wiggins GAR; Hakkaart C; Cree SL; Behar R; Houdayer C; ; Parsons MT; Kennedy MA; Spurdle AB; de la Hoya M
Front Genet; 2019; 10():1139. PubMed ID: 31803232
[No Abstract] [Full Text] [Related]
2. Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report.
Lopez-Perolio I; Leman R; Behar R; Lattimore V; Pearson JF; Castéra L; Martins A; Vaur D; Goardon N; Davy G; Garre P; García-Barberán V; Llovet P; Pérez-Segura P; Díaz-Rubio E; Caldés T; Hruska KS; Hsuan V; Wu S; Pesaran T; Karam R; Vallon-Christersson J; Borg A; ; Valenzuela-Palomo A; Velasco EA; Southey M; Vreeswijk MPG; Devilee P; Kvist A; Spurdle AB; Walker LC; Krieger S; de la Hoya M
J Med Genet; 2019 Jul; 56(7):453-460. PubMed ID: 30890586
[TBL] [Abstract][Full Text] [Related]
3. Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants.
Sanoguera-Miralles L; Valenzuela-Palomo A; Bueno-Martínez E; Esteban-Sánchez A; Lorca V; Llinares-Burguet I; García-Álvarez A; Pérez-Segura P; Infante M; Easton DF; Devilee P; Vreeswijk MPG; de la Hoya M; Velasco-Sampedro EA
Clin Chem; 2024 Jan; 70(1):319-338. PubMed ID: 37725924
[TBL] [Abstract][Full Text] [Related]
4. Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants.
Valenzuela-Palomo A; Bueno-Martínez E; Sanoguera-Miralles L; Lorca V; Fraile-Bethencourt E; Esteban-Sánchez A; Gómez-Barrero S; Carvalho S; Allen J; García-Álvarez A; Pérez-Segura P; Dorling L; Easton DF; Devilee P; Vreeswijk MP; de la Hoya M; Velasco EA
J Pathol; 2022 Mar; 256(3):321-334. PubMed ID: 34846068
[TBL] [Abstract][Full Text] [Related]
5. Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
Thomassen M; Mesman RLS; Hansen TVO; Menendez M; Rossing M; Esteban-Sánchez A; Tudini E; Törngren T; Parsons MT; Pedersen IS; Teo SH; Kruse TA; Møller P; Borg Å; Jensen UB; Christensen LL; Singer CF; Muhr D; Santamarina M; Brandao R; Andresen BS; Feng BJ; Canson D; Richardson ME; Karam R; Pesaran T; LaDuca H; Conner BR; Abualkheir N; Hoang L; Calléja FMGR; Andrews L; James PA; Bunyan D; Hamblett A; Radice P; Goldgar DE; Walker LC; Engel C; Claes KBM; Macháčková E; Baralle D; Viel A; Wappenschmidt B; Lazaro C; Vega A; ; Vreeswijk MPG; de la Hoya M; Spurdle AB
Hum Mutat; 2022 Dec; 43(12):1921-1944. PubMed ID: 35979650
[TBL] [Abstract][Full Text] [Related]
6. Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events.
de Jong LC; Cree S; Lattimore V; Wiggins GAR; Spurdle AB; ; Miller A; Kennedy MA; Walker LC
Breast Cancer Res; 2017 Nov; 19(1):127. PubMed ID: 29183387
[TBL] [Abstract][Full Text] [Related]
7. APPLICATION OF THE ACMG/AMP FRAMEWORK TO CAPTURE EVIDENCE RELEVANT TO PREDICTED AND OBSERVED IMPACT ON SPLICING: RECOMMENDATIONS FROM THE CLINGEN SVI SPLICING SUBGROUP.
Walker LC; de la Hoya M; Wiggins GAR; Lindy A; Vincent LM; Parsons MT; Canson DM; Bis-Brewer D; Cass A; Tchourbanov A; Zimmermann H; Byrne AB; Pesaran T; Karam R; Harrison S; Spurdle AB
medRxiv; 2023 Feb; ():. PubMed ID: 36865205
[TBL] [Abstract][Full Text] [Related]
8. A systematic assessment of the impact of rare canonical splice site variants on splicing using functional and in silico methods.
Oh RY; AlMail A; Cheerie D; Guirguis G; Hou H; Yuki KE; Haque B; Thiruvahindrapuram B; Marshall CR; Mendoza-Londono R; Shlien A; Kyriakopoulou LG; Walker S; Dowling JJ; Wilson MD; Costain G
HGG Adv; 2024 Apr; 5(3):100299. PubMed ID: 38659227
[TBL] [Abstract][Full Text] [Related]
9. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup.
Walker LC; Hoya M; Wiggins GAR; Lindy A; Vincent LM; Parsons MT; Canson DM; Bis-Brewer D; Cass A; Tchourbanov A; Zimmermann H; Byrne AB; Pesaran T; Karam R; Harrison SM; Spurdle AB;
Am J Hum Genet; 2023 Jul; 110(7):1046-1067. PubMed ID: 37352859
[TBL] [Abstract][Full Text] [Related]
10. Evaluating ClinGen variant curation expert panels' application of PVS1 code.
Wang X; Li H; Luo H; Zou Y; Li H; Qin Y; Song J
Eur J Med Genet; 2024 Feb; 67():104909. PubMed ID: 38199457
[TBL] [Abstract][Full Text] [Related]
11. Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants.
Bueno-Martínez E; Sanoguera-Miralles L; Valenzuela-Palomo A; Esteban-Sánchez A; Lorca V; Llinares-Burguet I; Allen J; García-Álvarez A; Pérez-Segura P; Durán M; Easton DF; Devilee P; Vreeswijk MP; de la Hoya M; Velasco-Sampedro EA
J Pathol; 2022 Sep; 258(1):83-101. PubMed ID: 35716007
[TBL] [Abstract][Full Text] [Related]
12. RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant.
Rofes P; Pineda M; Feliubadaló L; Menéndez M; de Cid R; Gómez C; Montes E; Capellá G; Brunet J; Del Valle J; Lázaro C
Sci Rep; 2021 Nov; 11(1):22948. PubMed ID: 34824355
[TBL] [Abstract][Full Text] [Related]
13. Differential Expression of
McDougall LI; Powell RM; Ratajska M; Lynch-Sutherland CF; Hossain SM; Wiggins GAR; Harazin-Lechowska A; Cybulska-Stopa B; Motwani J; Macaulay EC; Reid G; Walker LC; Ryś J; Eccles MR
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33672422
[TBL] [Abstract][Full Text] [Related]
14. Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity.
Hirschi OR; Felker SA; Rednam SP; Vallance KL; Parsons DW; Roy A; Cooper GM; Plon SE
medRxiv; 2023 Nov; ():. PubMed ID: 37961416
[TBL] [Abstract][Full Text] [Related]
15. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
[TBL] [Abstract][Full Text] [Related]
16. Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2.
Mesman RLS; Calléja FMGR; de la Hoya M; Devilee P; van Asperen CJ; Vrieling H; Vreeswijk MPG
Genet Med; 2020 Aug; 22(8):1355-1365. PubMed ID: 32398771
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer-rich regions and 38 spliceogenic variants.
Sanoguera-Miralles L; Llinares-Burguet I; Bueno-Martínez E; Ramadane-Morchadi L; Stuani C; Valenzuela-Palomo A; García-Álvarez A; Pérez-Segura P; Buratti E; de la Hoya M; Velasco-Sampedro EA
J Pathol; 2024 Apr; 262(4):395-409. PubMed ID: 38332730
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report.
Agiannitopoulos K; Papadopoulou E; Tsaousis GN; Pepe G; Kampouri S; Kocdor MA; Nasioulas G
BMC Med Genet; 2019 Jul; 20(1):131. PubMed ID: 31349801
[TBL] [Abstract][Full Text] [Related]
19. Dynamic nanopore long-read sequencing analysis of HIV-1 splicing events during the early steps of infection.
Nguyen Quang N; Goudey S; Ségéral E; Mohammad A; Lemoine S; Blugeon C; Versapuech M; Paillart JC; Berlioz-Torrent C; Emiliani S; Gallois-Montbrun S
Retrovirology; 2020 Aug; 17(1):25. PubMed ID: 32807178
[TBL] [Abstract][Full Text] [Related]
20. Novel alternative splice variants of the human protein arginine methyltransferase 1 (PRMT1) gene, discovered using next-generation sequencing.
Adamopoulos PG; Mavrogiannis AV; Kontos CK; Scorilas A
Gene; 2019 May; 699():135-144. PubMed ID: 30849541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
